On Sept. 25, the U.S. Food and Drug Administration (FDA) approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve glucose control in adults with diabetes mellitus. Read more. 

FDA approves new drugs for diabetes

WHO issues new HIV treatment recommendations

The Joint Commission issues Sentinel Event Alert on falls

The ABCDEs of emergency burn care

Afraid at work

Quiz time – October 2015

What works: Implementing an evidence-based nursing dress code to enhance professional image

Courage in everyday nursing practice

Viewpoint: Putting money at the bedside

Adolescents and marijuana: What nurses need to know

What works: An ED goes vertical to improve patient flow and satisfaction

From our readers: One patient’s story

Translational perspectives on violence

Saturated fats too often replaced with unhealthy alternatives

Blood Pressure: Make Control Your Goal Infographic

Study highlights which fruits and vegetables can aid weight loss

FDA approves new drugs

Certain subtypes of delirium may signal end of life for terminally ill patients with cancer

New report calls for improvement in diagnosing

New antibody offers hope in fight against C. difficile infection

Quiz time – 9/22

Nurse leaders and change

Meaningful use is a workforce issue

How an evening coffee can disrupt our body clock

MRSA persists in community

Suicide underestimated in U.S.

Antibacterial soap may be no more effective than plain soap

Tracking Down the Salt in Food with Professor Saul T. infographic

Natural compound could reduce breast cancer risk in some women

Preventing central line–associated bloodstream infections

Catheter-Associated Urinary Tract Infection Prevention Tool

Operationalizing the ANA CAUTI prevention tool in acute-care settings

Preventing medication errors by empowering patients

The business case for optimizing the nursing workforce

Caring for patients with solid organ transplants

Moving toward zero hospital-acquired infections